Back to search
Generated on www.datasnoop.be
Sint Lenaartseweg, 48, 2320 HoogstratenNACE 21201 — Vervaardiging van geneesmiddelen
Key FinancialsFY2024
Revenue
—
EBITDA
-€16K
↓ 157.2%
Margin
—
Employees
—
Leverage
0.0x
Net Debt / EBITDA
Equity Ratio
97.9%
Equity / Assets
Int. Coverage
-327.1x
EBITDA / Int. Exp
DSO
—
Days to collect
DPO
—
Days to pay
Financial History Summary
| Year | Revenue | EBITDA | Margin | Net Profit | FTE |
|---|---|---|---|---|---|
| 2024 | — | -€16K -€10K ▼ -157.2% | — | -€16K -€10K ▼ -156.0% | — |
| 2023 | — | -€6K -€2K ▼ -68.2% | — | -€6K -€2K ▼ -62.8% | — |
| 2022 | — | -€4K | — | -€4K | — |
Key People(1)
VO
Recent Publications(59)
DIVERSEN - DOEL - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING
2024-01-12· #0324334
ONTSLAGEN - BENOEMINGEN
2024-01-05· #0003334
ONTSLAGEN - BENOEMINGEN
2021-04-27· #0050877
ONTSLAGEN - BENOEMINGEN
2017-12-20· #0178760
ONTSLAGEN - BENOEMINGEN
2017-06-14· #0083093
Publication
2016-07-01· #0133538
Key Shareholders
No shareholder data
Key Subsidiaries
No subsidiary data